Nueva Ecija orders 300,000 doses from AstraZeneca | Inquirer News
Close  
INOCULATION PLAN

Nueva Ecija orders 300,000 doses from AstraZeneca

/ 05:00 AM January 17, 2021

CABANATUAN CITY, Nueva Ecija, Philippines — The Nueva Ecija provincial government has secured 300,000 doses of vaccine from British pharmaceutical AstraZeneca in a tripartite agreement with the national government, the province’s chief executive said.

Gov. Aurelio Umali said the vaccines can immunize 750,000 residents.

ADVERTISEMENT

He said the provincial government realigned budgets, such as the allocations for the special education fund, for the procurement and has been assured of more funds from the provincial board. He added that he would coordinate the vaccine rollout with Nueva Ecija mayors.

The national government will take care of inoculating poor families entitled to stipends from the Pamilyang Pantawid Pilipino Program, as well as front-liners.

FEATURED STORIES

“The national immunization subsidy will cover more or less 900,000 residents of Nueva Ecija,” Umali said. —ARMAND GALANG

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: AstraZeneca, coronavirus pandemic, coronavirus Philippines, Nueva Ecija COVID-19 vaccine purchase
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.